- Trials with a EudraCT protocol (374)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
374 result(s) found for: Renal replacement therapy.
Displaying page 1 of 19.
EudraCT Number: 2012-005617-39 | Sponsor Protocol Number: WS2030571 | Start Date*: 2014-01-14 |
Sponsor Name:University Hospital Tuebingen | ||
Full Title: Pharmacokinetics of Tigecycline in Patients Receiving Continuous Renal Replacement Therapy | ||
Medical condition: Surgical ICU patients with severe infection and renal replacement therapy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000899-16 | Sponsor Protocol Number: UMM022013TG | Start Date*: 2013-10-16 |
Sponsor Name:Department of Pharmacy Unversitätsmedizin Mainz | ||
Full Title: Investigation of pharmacokinetics of Linezolid and Meropenem in patients receiving continuous renal replacement therapy | ||
Medical condition: Sepsis and acute renal failure (ARF) are pathological entities that commonly co-exist in patients admitted to intensive care. Antibiotic dosing in septic patients with ARF can be complicated and ma... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004361-12 | Sponsor Protocol Number: FER-CIT-2016-01 | Start Date*: 2017-03-27 | ||||||||||||||||
Sponsor Name:Fernando Sánchez | ||||||||||||||||||
Full Title: Oxidative stress and extracellular nucleosomes in critically ill patients with acute kidney failure treated with continuous renal replacement therapies. Effect of two anticoagulation strategies of ... | ||||||||||||||||||
Medical condition: Acute renal failure (ARF). | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-001019-95 | Sponsor Protocol Number: COLIMICINA | Start Date*: 2021-05-31 | |||||||||||
Sponsor Name:FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE | |||||||||||||
Full Title: Pharmacokinetic/pharmacodynamic aspects of colistin intravenous administration in critically ill patients suffering from hospital infections caused by multi-antibiotic-resistant germs and receiving... | |||||||||||||
Medical condition: Critically ill patients suffering from hospital infections caused by multi-antibiotic-resistant germs and receiving continuous renal replacement therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004854-33 | Sponsor Protocol Number: 03-AnIt-14/UKM14_0066 | Start Date*: 2016-02-05 | ||||||||||||||||
Sponsor Name:University Hospital Muenster | ||||||||||||||||||
Full Title: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH-Trial). | ||||||||||||||||||
Medical condition: Critically ill patients with acute kidney injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-006014-20 | Sponsor Protocol Number: FARM6X822T | Start Date*: 2009-01-19 | |||||||||||
Sponsor Name:CONSORZIO MARIO NEGRI SUD | |||||||||||||
Full Title: Effects of the dose of erythropoiesis stimulating agents on cardiac-cerebrovascular outcomes and quality of life in hemodialysis patients. The DOSe of Erythropoietins (DOSE) trial. | |||||||||||||
Medical condition: End stage kidney disease and anemia, treated with hemodialysis for renal replacement therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002329-84 | Sponsor Protocol Number: APHP211039 | Start Date*: 2023-01-06 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Eculizumab in hypertensive emergency-associated hemolytic uremic syndrome: a randomized multicenter controlled trial. | |||||||||||||
Medical condition: Adult patients with aHUS associated with HE and severe kidney involvement (needing dialysis or serum creatinine ≥ 354µM). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002077-12 | Sponsor Protocol Number: MR-2008/001 | Start Date*: 2008-09-24 | |||||||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PERUGIA | |||||||||||||||||||||||
Full Title: Fenoldopam end Renal failure (FENO-HSR) | |||||||||||||||||||||||
Medical condition: Renal failure from ipoperfusion post Cardiac surgery | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021369-66 | Sponsor Protocol Number: UMM062010FS | Start Date*: 2010-11-16 |
Sponsor Name:Department of Pharmacy Universitaetsmedizin Mainz | ||
Full Title: Investigation of pharmacokinetics of Ciprofloxacin and Piperacillin/Tazobactam in Patients receiving continuous renal replacement therapy | ||
Medical condition: Sepsis and acute renal failure (ARF) are two pathological entities that commonly co-exist in patients admitted to intensive care. Antibiotic dosing in septic patients with ARF can be complicated a... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000948-98 | Sponsor Protocol Number: H-3-2011-154 | Start Date*: 2012-05-03 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Effect of epinephrine on systemic absorption of mepivacaine administered for brachial plexus block in patients with end-stage renal disease | |||||||||||||
Medical condition: End-stage renal disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013159-31 | Sponsor Protocol Number: CS/2009/3292 | Start Date*: 2010-02-25 |
Sponsor Name:University Hospitals Bristol NHS Foundation Trust | ||
Full Title: Preoperative volume replacement vs. usual care in diabetic patients having CABG surgery: a randomised controlled trial | ||
Medical condition: Coronary artery bypass grafting in diabetic patients | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-002069-11 | Sponsor Protocol Number: 1 | Start Date*: 2008-09-10 | ||||||||||||||||
Sponsor Name:Medizinische Universität Wien, Univ. Klinik für Innere Medizin III, Abteilung für Gastroenterologie | ||||||||||||||||||
Full Title: PHARMACOKINETICS OF GANCICLOVIR DURING CONTINUOUS RENAL REPLACEMENT THERAPY | ||||||||||||||||||
Medical condition: Medical Intensive Care Unit Renal failure Renal Replacement Therapy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-023455-28 | Sponsor Protocol Number: 11102010 | Start Date*: 2010-12-15 | |||||||||||
Sponsor Name:Maija Kaukonen | |||||||||||||
Full Title: Dexmedetomidine pharmacokinetics during continuous venovenous hemofiltration and hemodiafiltration in critically ill patients | |||||||||||||
Medical condition: Intensive care patients with acute kidney injury requiring continuous renal replacement therapy with a clinical indication for sedation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005551-36 | Sponsor Protocol Number: NL79416.018.21 | Start Date*: 2022-08-05 |
Sponsor Name: | ||
Full Title: Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock from Acute Myocardial Infarction: A Multicenter Randomized... | ||
Medical condition: Myocardial infarction related cardiogenic shock | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) DK (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004050-29 | Sponsor Protocol Number: PHI116581 | Start Date*: 2013-01-07 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: A four-week Phase IIa, randomized, double-blind, placebocontrolled, parallel-group, multi-center study to evaluate the safety, efficacy and pharmacokinetics of GSK1278863 in subjects with anemia as... | |||||||||||||
Medical condition: Anemia associated with chronic kidney disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004049-34 | Sponsor Protocol Number: PHI116582 | Start Date*: 2013-01-07 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: A four-week, Phase IIa, randomized, active-controlled, parallel-group, multi-center study to evaluate the safety, efficacy and pharmacokinetics of switching subjects from a stable dose of recombina... | |||||||||||||
Medical condition: Anaemia associated with chronic kidney disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NO (Completed) SE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000904-14 | Sponsor Protocol Number: MICA_HDF | Start Date*: 2012-07-19 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: PHARMACOKINETICS OF MICAFUNGIN DURING CONTINUOUS VENOVENOUS HEMOFILTRATION | |||||||||||||
Medical condition: Suspected or proven candida infection requiring parenteral antifungal therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001824-36 | Sponsor Protocol Number: 201201 | Start Date*: 2012-07-12 | ||||||||||||||||
Sponsor Name:Medical University of Vienna, Department of Medicine III, Division of Nephrology und Dialysis | ||||||||||||||||||
Full Title: ORAL SODIUM BICARBONATE SUPPLEMENTATION IN PATIENTS WITH CHRONIC METABOLIC ACIDOSIS AND CHRONIC KIDNEY DISEASE | ||||||||||||||||||
Medical condition: Patients classified to have chronic kidney disease of stage 3 and 4 and chronic metabolic acidosis (venous serum HCO3- of <21mml/L on 2 separate measurements at least 1 day apart) should be include... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006789-19 | Sponsor Protocol Number: NephroD_2021 | Start Date*: 2022-05-16 | |||||||||||
Sponsor Name:USK w Opolu | |||||||||||||
Full Title: Efficacy comparison of two doses of vitamin D3 in critically ill patients undergoing continuous renal replacement therapy - NephroD | |||||||||||||
Medical condition: Vitamin D3 deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002682-19 | Sponsor Protocol Number: PHI113633 | Start Date*: 2013-12-20 | |||||||||||
Sponsor Name:GlaxoSmithKline, S.A. | |||||||||||||
Full Title: A Phase 2B, randomized, blinded, dose-ranging, active-controlled, parallel-group, multi-center study to evaluate the dose response relationship of GSK1278863 over the first 4 weeks of treatment and... | |||||||||||||
Medical condition: Anemia associated with chronic kidney disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) SE (Completed) CZ (Completed) GB (Completed) DK (Completed) HU (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
